Polypharmacology: challenges and opportunities in drug discovery
- PMID: 24946140
- DOI: 10.1021/jm5006463
Polypharmacology: challenges and opportunities in drug discovery
Abstract
At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biological target, shares the spotlight with an emerging and alternative polypharmacology approach. Polypharmacology suggests that more effective drugs can be developed by specifically modulating multiple targets. It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches. In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs. In this review, we will compare advantages and disadvantages of multitarget versus combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.
Similar articles
-
Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.Curr Pharm Des. 2016;22(21):3171-81. doi: 10.2174/1381612822666160224142812. Curr Pharm Des. 2016. PMID: 26907941 Review.
-
Polypharmacology - foe or friend?J Med Chem. 2013 Nov 27;56(22):8955-71. doi: 10.1021/jm400856t. Epub 2013 Aug 22. J Med Chem. 2013. PMID: 23919353 Review.
-
GES polypharmacology fingerprints: a novel approach for drug repositioning.J Chem Inf Model. 2014 Mar 24;54(3):720-34. doi: 10.1021/ci4006723. Epub 2014 Feb 17. J Chem Inf Model. 2014. PMID: 24494653
-
Epigenetic polypharmacology: from combination therapy to multitargeted drugs.Clin Epigenetics. 2016 Oct 12;8:105. doi: 10.1186/s13148-016-0271-9. eCollection 2016. Clin Epigenetics. 2016. PMID: 27752293 Free PMC article. Review.
-
Turning liabilities into opportunities: Off-target based drug repurposing in cancer.Semin Cancer Biol. 2021 Jan;68:209-229. doi: 10.1016/j.semcancer.2020.02.003. Epub 2020 Feb 7. Semin Cancer Biol. 2021. PMID: 32044472 Free PMC article. Review.
Cited by
-
A Study to Decipher the Potential Effects of Butylphthalide against Central Nervous System Diseases Based on Network Pharmacology and Molecular Docking Integration Strategy.Evid Based Complement Alternat Med. 2021 May 4;2021:6694698. doi: 10.1155/2021/6694698. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34035826 Free PMC article.
-
Artificial intelligence to deep learning: machine intelligence approach for drug discovery.Mol Divers. 2021 Aug;25(3):1315-1360. doi: 10.1007/s11030-021-10217-3. Epub 2021 Apr 12. Mol Divers. 2021. PMID: 33844136 Free PMC article. Review.
-
Drug reprofiling history and potential therapies against Parkinson's disease.Front Pharmacol. 2022 Oct 26;13:1028356. doi: 10.3389/fphar.2022.1028356. eCollection 2022. Front Pharmacol. 2022. PMID: 36386233 Free PMC article. Review.
-
A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.Eur J Med Chem. 2021 Oct 15;222:113569. doi: 10.1016/j.ejmech.2021.113569. Epub 2021 May 29. Eur J Med Chem. 2021. PMID: 34111829 Free PMC article.
-
A Senomorphlytic Three-Drug Combination Discovered in Salsola collina for Delaying Aging Phenotypes and Extending Healthspan.Adv Sci (Weinh). 2024 Sep;11(36):e2401862. doi: 10.1002/advs.202401862. Epub 2024 Jul 29. Adv Sci (Weinh). 2024. PMID: 39073681 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources